About 100 reports

  • SCHIZOPHRENIA

You can easily book an appointment with one online.

  • Psychotic Disorder
  • World
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • GENE THERAPY TO REVERSE THE PROGRESSION OF PD
  • MARKET OVERVIEW

According to some studies, PD is a neurological disorder caused by genetic mutations.

  • Psychotic Disorder
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • 2.1 Psychosis: An Overview

Genetic factors include a variety of common and rare genetic variants.

  • Psychotic Disorder
  • World
  • Market Size
  • Johnson & Johnson
  • Lundbeck Inc.
  • SCHIZOPHRENIA

You can easily book an appointment with one online.

  • Psychotic Disorder
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • 06. Introduction
  • 12.1 Parkinson's Disease: Overview

The disease can be genetically inherited or caused by unknown factors.

  • Psychotic Disorder
  • Biogen Idec Inc.
  • Merck Serono S.A.
  • Novartis AG
  • Pfizer Inc.

Schizophrenia

4546 5000 3864
  • A DEEPER KNOWLEDGE OF SCHIZOPHRENIA'S CAUSES COULD HELP FURTHER DRUG DEVELOPMENT
  • Disease Definition and Diagnosis

Rather than one or two disease alleles being implicated across all schizophrenia cases, it is probable that genetic predisposition arises from a large number of copy number variants (CNVs) (Gershon et al., 2011).

  • Psychotic Disorder
  • European Union
  • Japan
  • United States
  • Alkermes plc
  • B. Introduction to CNS Disorders
  • Parkinson's Disease

The genetic makeup of E. coli is the best Dementia: Severe impairment of mental functioning.

  • Hospital
  • Psychotic Disorder
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.

ADHD also has a strong genetic component.

  • Psychotic Disorder
  • China
  • Trade
  • AstraZeneca China Inc.
  • Beijing Sihuan Pharmaceutical Co., Ltd.

ADHD also has a strong genetic component.

  • Psychotic Disorder
  • China
  • Market Size
  • Trade
  • Beijing Sihuan Pharmaceutical Co., Ltd.
  • 2.1 DISEASE BACKGROUND

Biological Insights from ## Schizophrenia-Associated Genetic Loci.

  • Psychotic Disorder
  • Japan
  • United Kingdom
  • United States
  • Forecast
  • NEUROLOGICAL AND MOVEMENT DISORDERS

THESE ARE THE COMPLEX DISORDERS AND ARE CAUSED DUE TO VARIOUS GENETIC AND ENVIRONMENTAL FACTORS.

  • Psychotic Disorder
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.

Even optogenetic stimulation needs genetic modification.

  • Psychotic Disorder
  • World
  • Boston Scientific Corporation
  • Cyberonics, Inc.
  • Jude Medical, Inc.
  • 2.1 Disease Introduction
  • Secondary symptoms

Research has provided a more elaborate view on the genetic mutation in patients with PD (see Table ##).

  • Psychotic Disorder
  • World
  • Forecast
  • Novartis AG
  • Parkinson Study Group
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY
  • 4.2 RISK FACTORS AND COMORBIDITIES

IMAGING ], blood and genetic testing.

  • Psychotic Disorder
  • Alkermes plc
  • Janssen Biotech, Inc.
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • DIAGNOSIS OF THE DISEASE
  • REFERENCES

Tohoku J Exp Med. 2010; ##(##):##-## ##.

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • North America
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY
  • 4.1 DISEASE BACKGROUND

MANY STUDIES HAVE CONCLUDED THAT THE GENETIC COMPONENT IS AN IMPORTANT RISK FACTOR FOR PARKINSON' S DISEASE.

  • Psychotic Disorder
  • Forecast
  • Market Size
  • Merck & Co., Inc.
  • Novartis AG

TABLE OF CONTENTS ##.

  • Psychotic Disorder
  • United States
  • genOway SA
  • Lexicon
  • Taconic Farms, Inc.
  • CAUSE OF THE DISEASE
  • INTRODUCTION

Schizophr Res. 2008; ##(##-##):##-## ##.

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Northern Europe
  • Western Europe

## (Cyclooxygenase-## or COX-## or Prostaglandin- Endoperoxide Synthase ## or EC ##. ##. ##. ##) Prostaglandin G/ H Synthase ## (Cyclooxygenase-## or COX-## or Prostaglandin- Endoperoxide Synthase ## or EC ##. ##. ##. ##) ## ## ## ## ## ## ## ## ## ALK Tyrosine Kinase

  • Psychotic Disorder
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited

Global Designer Baby Trends Industry ##.

  • Mental Health
  • Neurological Disorder
  • Pathology
  • Psychotic Disorder
  • World
  • SMALL MOLECULES TO ACTIVATE GCASE FOR PARKINSON'S DISEASE - DRUG PROFILE

Using Pfizer GPS, patients and healthcare professionals can access all support services ##/ ## using one toll-free phone number, ##-##-ELELYSO (##-##-##- ##).

  • Psychotic Disorder
  • Therapy
  • Brazil
  • Product Initiative
  • Protalix BioTherapeutics, Inc.
  • GENETIC TEST - SCHIZOPHRENIA - PRODUCT STATUS
  • CLIA WAIVED GENETIC TEST - ENDOMETRIOSIS - PRODUCT STATUS

Inborn Gene or Chromosome Alterations Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary GlobalData’s Medical Devices sector report, “Inborn Gene or Chromosome Alterations Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Inborn Gene or Chromosome Alterations Diagnostic...

  • Clinical Trial
  • Hospital
  • Nucleic Acid
  • Psychotic Disorder
  • GlobalData's company

Genetic Factors Linked to Parkinson’s Disease PARK## (parkin/ ubiquitin E## ligase) PINK## (PTEN-induced kinase ## protein) GBA (glucocerebrosidase) Promising Biomarkers for Parkinson’s Disease SNCA (?

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Product Development Milestones
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

The Center for Applied Genomics (CAG) at The Children' s Hospital of Philadelphia (CHOP) founded neuroFix to pursue development of NFC-## following a breakthrough genetic discovery.

  • Neurological Disorder
  • Psychotic Disorder
  • United States
  • World
  • Product Initiative
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Product Development Milestones

In the second half of this year, Aevi Genomics plans to initiate a Phase ## trial of AEVI-## in a smaller genetic subset to confirm genetic responders.

  • Psychotic Disorder
  • Therapy
  • World
  • Product Initiative
  • Addex Therapeutics Ltd

AN ATTRACTIVE ALTERNATIVE TO THE USE OF GENETICALLY ENGINEERED FIBROBLASTS IS IMMORTALIZED NSCS, WHICH ARE CREATED VIA GENETIC MANIPULATION.

  • Psychotic Disorder
  • North America
  • United States
  • Athersys, Inc.
  • Vericel Corporation
  • PAIN

THE PURCHASE OF ONE COMPANY BY ANOTHER.

  • Gene Therapy
  • Psychotic Disorder
  • Therapy
  • United States
  • uniQure N.V.
  • Genetic Test - Schizophrenia Genetic Test - Schizophrenia Product Overview
  • Genetic Test - Schizophrenia - Product Status

Summary Population Diagnostics Inc (Population Diagnostics) is a biotechnology company that carries out the research, development and discovery of platform technology for validation of causative genetic biomarkers. The company develops various therapeutic areas such as novel targeted drugs, drug rescue of Phase II & III failures,...

  • In Vitro Diagnostic Reagent
  • Psychotic Disorder
  • Turkey
  • United States
  • GlobalData's company
  • NEURODEGENERATIVE DISEASE DRUGS MARKET, GLOBAL, ALZHEIMER'S DISEASE NEUROLOGICAL
  • 2.6.1 ALZHEIMER'S DISEASE

Familial cases of PD have genetic mutations relating to a key process in one of these pathways.

  • Psychotic Disorder
  • World
  • Company
  • Company Financials
  • Forecast
  • Introduction
  • Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Product Development Milestones

The Center for Applied Genomics (CAG) at The Children' s Hospital of Philadelphia (CHOP) founded neuroFix to pursue development of NFC-## following a breakthrough genetic discovery.

  • Psychotic Disorder
  • United States
  • World
  • Product Initiative
  • Addex Therapeutics Ltd